Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: Promising but inconclusive evidence of superiority, compared with antimony monotherapy [1]
Overview
Fingerprint
Cite this